ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
University of Cambridge at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University of Cambridge takes part in 10 sessions at ESMO 2026 in Madrid. Its work spans cancer biomarkers and treatment across several tumour types. It examines immune cells in colorectal and endometrial cancers and tumour changes in early breast cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
University of Cambridge Cambridge, United Kingdom | |
Public research university in Cambridge, United Kingdom, with a clinical school and cancer research institutes. | Keynote Fri Oct 23 11:48–11:58 Poster Fri Oct 23 13:00–15:00 Investigation of TCRβ downregulation in T cells infiltrating colorectal and endometrial carcinomas Gastrointestinal cancersGynaecological cancers Talk Fri Oct 23 13:30 Talk Fri Oct 23 14:15–14:30 Poster Sat Oct 24 12:00–12:45 Identifying tumour and ctDNA clonal evolution in response to neoadjuvant radiotherapy and endocrine therapy in Stage I/II ER+ breast cancer Breast cancerBiomarkers & precision oncology Chair Sat Oct 24 14:45–16:15 Rare GU cancers Genitourinary cancers Talk Sun Oct 25 09:00 Chair Sun Oct 25 16:30–18:00 Peri-operative management of urothelial cancer Genitourinary cancers Talk Sun Oct 25 17:30–17:45 Reflection and implications for kidney cancer Genitourinary cancers Abstract Mon Oct 26 15:29–15:39 Talk Tue Oct 27 09:40–10:00 |
Find decision makers at University of Cambridge
Tell us what you sell and we’ll find the people at University of Cambridge most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction